132 related articles for article (PubMed ID: 38400747)
1. Therapeutic drug monitoring in pregnancy: Levetiracetam.
Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study.
Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B
Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482
[TBL] [Abstract][Full Text] [Related]
3. Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review.
Liu R; Xiao L; Liu X; Xiao C
Medicine (Baltimore); 2024 Apr; 103(17):e37977. PubMed ID: 38669358
[TBL] [Abstract][Full Text] [Related]
4. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy.
Schelhaas M; Wegner I; Edens M; Wammes-Van Der Heijden E; Touw D; Ter Horst P
Neurology; 2023 Jan; 100(2):e172-e181. PubMed ID: 36257713
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy.
Li Y; Wang ML; Guo Y; Cao YF; Zhao MM; Zhao LM
Br J Clin Pharmacol; 2023 Mar; 89(3):1152-1161. PubMed ID: 36260320
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy.
Kim JS; Kim WS; Sung WY; Woo H
Epilepsy Behav; 2024 May; 154():109740. PubMed ID: 38547767
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic levetiracetam monitoring during pregnancy: "mind the gap".
Berlin M; Barchel D; Gandelman-Marton R; Brandriss N; Blatt I; Ziv-Baran T; Neufeld MY; Dinavitser N; Kohn E; Shaniv D; De-Haan T; Ofek F; Koren G; Stepensky D; Berkovitch M
Ther Adv Chronic Dis; 2019; 10():2040622319851652. PubMed ID: 31191874
[TBL] [Abstract][Full Text] [Related]
8. Optimal Dosing of Levetiracetam for Seizure Prophylaxis in Critically Ill Patients: A Prospective Observational Study.
Valdes E; Fang T; Boffa M; Frontera JA
Crit Care Med; 2024 Jan; 52(1):e1-e10. PubMed ID: 37734033
[TBL] [Abstract][Full Text] [Related]
9. Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetam.
Schoemaker R; Krauwinkel W; Elshoff JP; Stockis A
Epilepsy Res; 2024 May; 202():107332. PubMed ID: 38518434
[TBL] [Abstract][Full Text] [Related]
10. Correlation of drug dose estimated from national prescription registers with mean blood level of antiseizure medication in pregnancy.
Christensen J; Trabjerg B; Dreier JW
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5811. PubMed ID: 38783423
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
Pennell PB; Peng L; Newport DJ; Ritchie JC; Koganti A; Holley DK; Newman M; Stowe ZN
Neurology; 2008 May; 70(22 Pt 2):2130-6. PubMed ID: 18046009
[TBL] [Abstract][Full Text] [Related]
12. Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
Pennell PB; Karanam A; Meador KJ; Gerard E; Kalayjian L; Penovich P; Matthews A; McElrath TM; Birnbaum AK;
JAMA Neurol; 2022 Apr; 79(4):370-379. PubMed ID: 35157004
[TBL] [Abstract][Full Text] [Related]
13. Seizure Deterioration with Increased Levetiracetam Blood Concentration during the Postpartum Period in Refractory Temporal Lobe Epilepsy.
Kikumoto M; Neshige S; Shishido T; Ueno H; Aoki S; Iida K; Maruyama H
Intern Med; 2022 Apr; 61(8):1237-1240. PubMed ID: 34615824
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic changes for newer antiepileptic drugs and seizure control during pregnancy.
Yin X; Liu Y; Guo Y; Zhao L; Li G; Tan X
CNS Neurosci Ther; 2022 May; 28(5):658-666. PubMed ID: 35037389
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.
Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ
Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra-performance liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy.
Zhang M; Jin Y; Li W; He C; Di X; Duan Y; Chen L; Wang Z
Biomed Chromatogr; 2024 Feb; 38(2):e5777. PubMed ID: 37990827
[TBL] [Abstract][Full Text] [Related]
17. Is the anticonvulsant activity of levetiracetam dose-dependent?
Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
[TBL] [Abstract][Full Text] [Related]
18. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy.
Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA
Seizure; 2020 May; 78():71-77. PubMed ID: 32213443
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
Mari L; Placidi F; Romigi A; Tombini M; Del Bianco C; Ulivi M; Liguori C; Manfredi N; Castelli A; Mercuri NB; Izzi F
Neurol Sci; 2022 Mar; 43(3):1993-2001. PubMed ID: 34468899
[TBL] [Abstract][Full Text] [Related]
20. Managing Antiseizure Medications in Pregnancy: Is Earlier and More Frequent Monitoring Better?
Freund B; Chen B; Kaplan PW; Johnson EL
Neurol Clin Pract; 2023 Aug; 13(4):e200169. PubMed ID: 37223248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
